140
Participants
Start Date
June 30, 2003
Primary Completion Date
September 30, 2005
Study Completion Date
September 30, 2006
Pegylated Liposomal Doxorubicin and Carboplatin
Medical Practice Dr. Klare, Berlin
Ernst-Moritz-Arndt University, Dept. of Gynecology & Obstetrics, Greifswald
Univerisity Clinic Schleswig-Holstein, Campus Kiel, Dept. for gynecology & obstetrics, Kiel
MH Hannover, Dept. of Gynecology & Obstetrics, Hanover
Phillips University, Clinic fo gynecology, gyn endocrinology and oncology, Marburg
Otto-von-Guericke Univerisity, Dept. of Gynecology & Obstetrics, Magdeburg
Evangelisches Krankenhaus, Dept. of Gynecology & Obstetrics, Düsseldorf
University hospital, Dept. of gynecology & obstetrics, Essen
University hospital, Dept. of Gynecology & Obstetrics, Mainz
University hospital , Dept. gynecologic & obestretics, Frankfurt
University hospital, Dept. gynecology & obstetrics, Tübingen
St. Vincentius Hospital, Dept. of Gynecology & Obstetrics, Karlsruhe
Schwarzwald-Baar Klinikum Villingen, Dept. Gynecology, Villingen-Schwenningen
University of Freiburg; Dept of Gynecology & Obstetrics, Freiburg im Breisgau
University hospital Muenchen-Grosshadern, Dept. of gynecology & obstetrics, München
University Hospital TU Muenchen; Dept. of Gynecology & Obstetrics, München
Univerisity Hospital; Dept. of Gynecology & Obstetrics, Erlangen
Humaine Vogtlandklinikum; Dept. of gynecology & obstetrics, Plauen
HSK, Dr. Horst Schmidt Klinik, Dept. of Gynecology & Gyn. Oncology, Wiesbaden
MedServ. GmbH, Wiesbaden
UNKNOWN
Essex Pharma GmbH
INDUSTRY
AGO Study Group
OTHER